{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:36:32Z","timestamp":1793230592621,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jacc.2024.06.015","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T10:02:45Z","timestamp":1723456965000},"page":"744-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Optimizing Management of Stable Angina"],"prefix":"10.1016","volume":"84","author":[{"given":"Rocco A.","family":"Montone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0559-2626","authenticated-orcid":false,"given":"Riccardo","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Niccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5552-6382","authenticated-orcid":false,"given":"Giuseppe","family":"And\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6943-278X","authenticated-orcid":false,"given":"Felice","family":"Gragnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pelliccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Moscarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zimarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9458-0736","authenticated-orcid":false,"given":"Enrico","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"de Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Italo","family":"Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6569-9401","authenticated-orcid":false,"given":"Francesco","family":"Burzotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Grigioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaide","family":"Chieffo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Capodanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Al-Lamee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom J.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Brugaletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1241-6487","authenticated-orcid":false,"given":"Ciro","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Perrone Filardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2024.06.015_bib1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Abbafati","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.06.015_bib2","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.118.031373","article-title":"Reappraisal of Ischemic Heart Disease","volume":"138","author":"Kaski","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.06.015_bib3","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jacc.2012.02.082","article-title":"Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link","volume":"60","author":"Marzilli","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib4","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","volume":"41","author":"Kunadian","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jacc.2022.08.814","article-title":"Evolving management paradigm for stable ischemic heart disease patients: JACC review topic of the week","volume":"81","author":"Boden","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2021.12.013","article-title":"Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease","volume":"348","author":"Mehta","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib7","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.jacc.2020.08.078","article-title":"Evaluation and management of patients with stable angina: beyond the ischemia paradigm: JACC state-of-the-art review","volume":"76","author":"Ferraro","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib8","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib9","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib10","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Neumann","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jacc.2021.09.005","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2023.04.003","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Virani","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib14","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib15","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A\u00a0randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve\u2013guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-year outcomes with pci guided by fractional flow reserve","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib18","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCULATIONAHA.122.062714","article-title":"Survival after invasive or conservative management of stable coronary disease","volume":"147","author":"Hochman","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.06.015_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.amjcard.2020.07.025","article-title":"Meta-analysis of the effect of percutaneous coronary intervention on death and myocardial infarction in patients with stable coronary artery disease and inducible myocardial ischemia","volume":"133","author":"Radaideh","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MCA.0000000000001041","article-title":"A\u00a0meta-analysis of optimal medical therapy with or without percutaneous coronary intervention in patients with stable coronary artery disease","volume":"33","author":"Shah","year":"2022","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jacc.2024.06.015_bib22","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1093\/eurheartj\/ehab246","article-title":"Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis","volume":"42","author":"Navarese","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib23","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1093\/eurheartj\/ehab330","article-title":"Impact of revascularisation on outcomes in chronic coronary syndromes: a new meta-analysis with the same old biases?","volume":"42","author":"Brown","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa072771","article-title":"Effect of PCI on quality of life in patients with stable coronary disease","volume":"359","author":"Weintraub","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib25","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004665","article-title":"\u201cFaith healing\u201d and \u201csubtraction anxiety\u201d in unblinded trials of procedures: lessons from DEFER and FAME-2 for endpoints in the ISCHEMIA trial","volume":"11","author":"Rajkumar","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.06.015_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.06.015_bib28","first-page":"1","article-title":"Achieving optimal medical therapy: insights from the ORBITA trial","volume":"10","author":"Foley","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.06.015_bib29","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa2310610","article-title":"A\u00a0placebo-controlled trial of percutaneous coronary intervention for stable angina","volume":"389","author":"Rajkumar","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib30","first-page":"1017","article-title":"Angina and associated healthcare costs following percutaneous coronary intervention: a real-world analysis from a multi-payer database","volume":"88","author":"Ben-Yehuda","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.06.015_bib31","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/eurheartj\/ehy857","article-title":"Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization","volume":"40","author":"Crea","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib32","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1177\/2047487318777435","article-title":"Endothelial dysfunction as predictor of angina recurrence after successful percutaneous coronary intervention using second generation drug eluting stents","volume":"25","author":"Montone","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2017.07.105","article-title":"Angina after percutaneous coronary intervention: the need for precision medicine","volume":"248","author":"Niccoli","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib34","first-page":"2319","article-title":"N-of-1 trial of angina verification before percutaneous coronary intervention","volume":"389","author":"Rajkumar","year":"2024","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0140-6736(21)02045-6","article-title":"What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?","volume":"399","author":"Boden","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.06.015_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2020.05.016","article-title":"Prevalence of angina and use of medical therapy among US adults: a nationally representative estimate","volume":"228","author":"Aggarwal","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/clc.22594","article-title":"Antianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease","volume":"39","author":"Shen","year":"2016","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005455","article-title":"Medical therapy utilization and long-term outcomes following percutaneous coronary intervention: five-year results from the Veterans Affairs clinical assessment, reporting, and tracking system program","volume":"12","author":"Xie","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.06.015_bib39","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/CIRCULATIONAHA.120.049755","article-title":"Outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity","volume":"144","author":"Reynolds","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.06.015_bib40","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(24)00413-6","article-title":"Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial","volume":"403","author":"Park","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.06.015_bib41","article-title":"Coronary atherosclerotic vulnerable plaque: current perspectives","volume":"6","author":"Stefanadis","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.06.015_bib42","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib43","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(17)32458-3","article-title":"Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Connolly","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.06.015_bib46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S2213-8587(17)30033-5","article-title":"Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes","volume":"5","author":"Standl","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2024.06.015_bib47","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/CIRCRESAHA.117.311588","article-title":"Cardiovascular effects of new oral glucose-lowering agents: DPP-4 and SGLT-2 inhibitors","volume":"122","author":"Scheen","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2024.06.015_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcmg.2011.09.020","article-title":"Is discordance of coronary flow reserve and fractional flow reserve due to methodology or clinically relevant coronary pathophysiology?","volume":"5","author":"Johnson","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2024.06.015_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044054","article-title":"Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial","volume":"11","author":"McCreanor","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2024.06.015_bib50","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"78","author":"Gulati","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib51","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa1406430","article-title":"Ivabradine in stable coronary artery disease without clinical heart failure","volume":"371","author":"Fox","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10557-016-6681-2","article-title":"Management of stable angina\u2014current guidelines: a critical appraisal","volume":"30","author":"Thadani","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2024.06.015_bib53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijcard.2015.08.045","article-title":"Unresolved issues in the management of chronic stable angina","volume":"201","author":"Camm","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib54","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijcard.2016.06.150","article-title":"Medical treatment of stable angina: a tailored therapeutic approach","volume":"220","author":"Manolis","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib55","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nrcardio.2017.131","article-title":"Expert consensus document: a \u201cdiamond\u201d approach to personalized treatment of angina","volume":"15","author":"Ferrari","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib56","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehn571","article-title":"Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial","volume":"30","author":"Tardif","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib57","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0140-6736(16)31326-5","article-title":"Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study","volume":"388","author":"Vidal-Petiot","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.06.015_bib58","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000362381","article-title":"The J-curve in arterial hypertension: fact or fallacy?","volume":"129","author":"Tsika","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2024.06.015_bib59","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"\u03b2-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.06.015_bib60","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","article-title":"Clinical outcomes with \u03b2-blockers for myocardial infarction: a meta-analysis of randomized trials","volume":"127","author":"Bangalore","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib61","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.06.015_bib62","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/hrt.2010.208751","article-title":"Trimetazidine: a meta-analysis of randomised controlled trials in heart failure","volume":"97","author":"Gao","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.06.015_bib63","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/CIRCULATIONAHA.107.724880","volume":"116","author":"Scirica","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.06.015_bib64","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1161\/CIRCEP.115.002856","article-title":"The HARMONY trial: combined ranolazine and dronedarone in the management of paroxysmal atrial fibrillation: mechanistic and therapeutic synergism","volume":"8","author":"Reiffel","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib65","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/heartjnl-2014-305482","article-title":"Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials","volume":"100","author":"Martin","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.06.015_bib66","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.jacc.2013.02.011","article-title":"Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina)","volume":"61","author":"Kosiborod","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib67","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(07)60108-1","article-title":"Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis","volume":"369","author":"Elliott","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.06.015_bib68","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00003088-200645050-00003","article-title":"Clinical pharmacokinetics of ranolazine","volume":"45","author":"Jerling","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jacc.2024.06.015_bib69","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinternmed.2010.112","article-title":"Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease","volume":"170","author":"Rutten","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib70","article-title":"Medication adherence in cardiovascular medicine","volume":"374","author":"Simon","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2024.06.015_bib71","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib72","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1093\/eurheartj\/ehab282","article-title":"Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group","volume":"42","author":"Shimokawa","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib73","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehab775","article-title":"Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis","volume":"43","author":"Kelshiker","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib74","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jcmg.2021.01.041","article-title":"Functional and economic impact of INOCA and influence of coronary microvascular dysfunction","volume":"14","author":"Schumann","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2024.06.015_bib75","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1253\/circj.CJ-21-0848","article-title":"Pathophysiology of coronary microvascular dysfunction","volume":"86","author":"Crea","year":"2022","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2024.06.015_bib76","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review","volume":"78","author":"Del Buono","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib77","doi-asserted-by":"crossref","first-page":"371","DOI":"10.31083\/j.rcm2311371","article-title":"Invasive functional coronary assessment in myocardial ischemia with non-obstructive coronary arteries: from pathophysiological mechanisms to clinical implications","volume":"23","author":"Rinaldi","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jacc.2024.06.015_bib78","doi-asserted-by":"crossref","first-page":"E666","DOI":"10.4244\/EIJ-D-21-00971","article-title":"Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and nonobstructive coronary arteries","volume":"18","author":"Montone","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2024.06.015_bib79","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.atherosclerosis.2020.12.008","article-title":"Coronary provocative tests in the catheterization laboratory: pathophysiological bases, methodological considerations and clinical implications","volume":"318","author":"Montone","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2024.06.015_bib80","first-page":"2565","article-title":"International standardization of diagnostic criteria for vasospastic angina","volume":"38","author":"Beltrame","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib81","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","article-title":"International standardization of diagnostic criteria for microvascular angina","volume":"250","author":"Ong","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib82","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial","volume":"72","author":"Ford","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib83","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcin.2019.11.001","article-title":"1-year outcomes of angina management guided by invasive coronary function testing (CorMicA)","volume":"13","author":"Ford","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2024.06.015_bib84","first-page":"67","article-title":"Angina or ischemia with no obstructed coronary arteries: a specific diagnostic and therapeutic protocol","volume":"6","author":"Rinaldi","year":"2024","journal-title":"REC Interv Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib85","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/0735-1097(93)90310-W","article-title":"Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group","volume":"21","author":"Chahine","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib86","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1253\/circj.CJ-10-0292","article-title":"Prognostic effects of calcium channel blockers in patients with vasospastic angina\u2014a meta-analysis","volume":"74","author":"Nishigaki","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2024.06.015_bib87","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0002-9149(85)90842-2","article-title":"Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve","volume":"56","author":"Cannon","year":"1985","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.jacc.2024.06.015_bib88","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/heartjnl-2022-321267","article-title":"Use of pharmacology in the diagnosis and management of vasomotor and microcirculation disorders","volume":"109","author":"McChord","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.06.015_bib89","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/eurheartj\/ehu313","article-title":"Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association","volume":"36","author":"Takahashi","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib90","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10557-013-6439-z","article-title":"Lack of effect of nitrates on exercise stress test results in patients with microvascular angina","volume":"27","author":"Russo","year":"2013","journal-title":"Cardiovasc drugs Ther"},{"key":"10.1016\/j.jacc.2024.06.015_bib91","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/cvr\/cvaa006","article-title":"Treatment of coronary microvascular dysfunction","volume":"116","author":"Bairey Merz","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2024.06.015_bib92","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0002-9149(99)00450-6","article-title":"Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X","volume":"84","author":"Lanza","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib93","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcmg.2014.12.008","article-title":"Coronary microvascular dysfunction, microvascular angina, and treatment strategies","volume":"8","author":"Marinescu","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2024.06.015_bib94","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.CIR.65.2.281","article-title":"Exacerbation of vasotonic angina pectoris by propranolol","volume":"65","author":"Robertson","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.06.015_bib95","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ahj.2011.07.011","volume":"162","author":"Pauly","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib96","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/HJH.0b013e328340a08e","article-title":"Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension","volume":"29","author":"Neglia","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2024.06.015_bib97","article-title":"Impact of statin therapy on clinical outcome in patients with coronary spasm","volume":"5","author":"Ishii","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.06.015_bib98","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A\u00a0randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Merz","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib99","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2013.02.045","article-title":"Effects of ivabradine and ranolazine in patients with microvascular angina pectoris","volume":"112","author":"Villano","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0002-9149(97)00279-8","article-title":"Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina","volume":"80","author":"Chen","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib101","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/hc1002.105938","article-title":"Suppression of coronary artery spasm by the rho-kinase inhibitor fasudil in patients with vasospastic angina","volume":"105","author":"Masumoto","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.06.015_bib102","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0735-1097(02)02632-3","article-title":"Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm","volume":"41","author":"Mohri","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib103","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2019.08.1056","article-title":"Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease","volume":"74","author":"Suda","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib104","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1093\/eurheartj\/ehz915","article-title":"Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction","volume":"41","author":"Ford","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ahj.2020.07.007","article-title":"Rationale and design of the Medical Research Council\u2019s Precision Medicine With Zibotentan in Microvascular Angina (PRIZE) trial","volume":"229","author":"Morrow","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib106","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.1995.03520350065031","article-title":"The sensitive heart. A syndrome of abnormal cardiac pain perception","volume":"273","author":"Cannon","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.06.015_bib107","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0735-1097(97)00421-X","article-title":"Role of abnormal pain sensitivity and behavioral factors in determining chest pain in syndrome X","volume":"31","author":"Pasceri","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib108","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIR.0b013e3182285a81","article-title":"Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association","volume":"124","author":"Weintraub","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.06.015_bib109","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib110","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"290","author":"Mach","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2024.06.015_bib111","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.06.015_bib112","doi-asserted-by":"crossref","first-page":"I-10-I","DOI":"10.1002\/clc.20047","article-title":"The burden of angina pectoris and\u00a0its complications","volume":"30","author":"Peterson","year":"2007","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2024.06.015_bib113","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Sousa-Uva","year":"2019","journal-title":"Eur Heart J"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724076265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724076265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:17:10Z","timestamp":1775002630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109724076265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":113,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0735109724076265"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.06.015","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing Management of Stable Angina","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}